Efficient generation of antileukemic autologous T cells by short-term culture and γ-irradiation of myeloid leukemic cells

Cancer Immunology, Immunotherapy

Volumn 53, Issue 9, 2004, Pages 793-798

  Vereecque, Rodolphe ^a,b   Saudemont, Aurore ^a,b   Depil, Stéphane ^a,b,c   Corm, Selim ^a,b,c   Andrieux, Joris ^a,b,c   Soenen Cornu, Valérie ^a,b,c   Quesnel, Bruno ^a,b,c  

^a Institut de Recherche sur le Cancer de Lille   (France)

^b Institut Federatif de Recherche 114   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antigen presenting cells; CD80; CD86; Irradiation; Leukemia

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ACUTE DISEASE; ADULT; AGED; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, NEOPLASM; AUTOANTIGENS; CELLS, CULTURED; FEMALE; GAMMA RAYS; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4344668403     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Claxton D, Choudhury A (2001) Potential for therapy with AML-derived dendritic cells. Leukemia 15:668
2. Cignetti A, Bryant E, Allione B, Vitale A, Foa R, Cheever MA (1999) CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94:2048
3. Harrison BD, Adams JA, Briggs M, Brereton ML, Yin JA (2001) Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Blood 97:2764-2771
4. Koski GK, Schwartz GN, Weng DE, Gress RE, Engels FH, Tsokos M, Czerniecki BJ, Cohen PA (1999) Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood 94:1359
5. Tsuchiya T, Hagihara M, Shimakura Y, Ueda Y, Gansuvd B, Munkhbat B, Inoue H, Tazume K, Kato S, Hotta T (2002) The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells. Int J Hematol 75:55
6. Panoskaltsis N, Belanger TJ, Liesveld JL, Abboud CN (2002) Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leuk Res 26:191
7. Galea-Lauri J, Darling D, Mufti G, Harrison P, Farzaneh F (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 51:299
8. Hagihara M, Shimakura Y, Tsuchiya T, Ueda Y, Gansuvd B, Munkhbat B, Chargui J, Ando K, Kato S, Hotta T (2001) The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro. Leuk Res 25:249
9. Oehler L, Berer A, Kollars M, Keil F, Konig M, Waclavicek M, Haas O, Knapp W, Lechner K, Geissler K (2000) Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia. Ann Hematol 79:355
10. Kohler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B, Schaekel U, Ehninger G, Bornhauser M (2000) Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 18:139
11. Choudhury BA, Liang JC, Thomas EK, Flores-Romo L, Xie QS, Agusala K, Sutaria S, Sinha I, Champlin RE, Claxton DF (1999) Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93:780
12. Charbonnier A, Gaugler B, Sainty D, Lafage-Pochitaloff M, Olive D (1999) Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol 29:2567
13. Choudhury A, Toubert A, Sutaria S, Charron D, Champlin RE, Claxton DF (1998) Human leukemia-derived dendritic cells: ex vivo development of specific antileukemic cytotoxicity. Crit Rev Immunol 18:121
14. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreeff M, Champlin RE (1997) Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89:1133
15. Eibl B, Ebner S, Duba C, Bock G, Romani N, Erdel M, Gachter A, Niederwieser D, Schuler G (1997) Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 20:215-223
16. Westers TM, Stam AG, Scheper RJ, Regelink JC, Nieuwint AW, Schuurhuis GJ, van de Loosdrecht AA, Ossenkoppele GJ (2003) Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol Immunother 52:17
17. Mohty M, Gaugler B, Olive D (2003) Generation of leukemic dendritic cells from patients with acute myeloid leukemia. Methods Mol Biol 215:463
18. Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Briere F, de Lamballeri XN, Isnardon D, Sainty D, Olive D, Gaugler B (2001) Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 98:3750
19. Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M (2002) Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Res 62:2861
20. Narita M, Takahashi M, Liu A, Nikkuni K, Furukawa T, Toba K, Koyama S, Takai K, Sanada M, Aizawa Y (2001) Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia. Exp Hematol 29:709
21. Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA, Olive D (2000) Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 60:4403
22. Vereecque R, Buffenoir G, Gonzalez R, Cambier N, Hetuin D, Bauters F, Fenaux P, Quesnel B (2000) Gamma-ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br J Haematol 108:825
23. Sojka DK, Donepudi M, Bluestone JA, Mokyr MB (2000) Melphalan and other anticancer modalities up-regulate B7-1 gene expression in tumor cells. J Immunol 164:6230
24. Donepudi M, Raychaudhuri P, Bluestone JA, Mokyr MB (2001) Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cells. J Immunol 166:6491
25. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck D W, Schmitz J (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037
26. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J (2001) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194:1823
27. Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, Vassiliadis J, Androulakis A, Meletis J, Rombos J, Tassiopoulou A, Vaiopoulos G (2003) An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Eur J Haematol 71:294
28. Claxton DF, McMannis J, Champlin R, Choudhury A (2001) Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress. Crit Rev Immunol 21:147